Integrated Technologies Create a Viable Supply Chain for a CAR T-Cell Immunotherapy

When Cryoport’s client experienced a problem with shippers tilting during transit, compromising the effectiveness of the liquid nitrogen coolant and jeopardizing a CAR T-cell immunotherapy clinical program, Cryoport solved it with a comprehensive solution. Read an in-depth description of the problem and how Cyroport's integrated packaging, monitoring, and software solution created a viable supply chain for the immunotherapy.

Download Now

Name *
Please enter your first and last name.
Company/Institution *
Please enter the name of the company or institution you work at.
Address *
Please enter your mailing address.
E-mail Address *
Please enter the e-mail address you would like to be contacted at.
Work Phone Number *
Please enter the phone number you would like to be contacted at.
Are you planning to purchase any lab products related to this content? *
By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to this documentary sponsor. You may request to be removed at any time.

Integrated Technologies Create a Viable Supply Chain for a CAR T-Cell Immunotherapy

Oops! It looks like there were some errors.

Download Now